nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Ocular discomfort—Methotrexate—esophageal cancer	0.0269	0.0336	CcSEcCtD
Flunisolide—Amcinonide—ANXA1—esophageal cancer	0.0256	0.303	CrCbGaD
Flunisolide—Pleurisy—Methotrexate—esophageal cancer	0.025	0.0313	CcSEcCtD
Flunisolide—Hoarseness—Capecitabine—esophageal cancer	0.0186	0.0233	CcSEcCtD
Flunisolide—Chest tightness—Capecitabine—esophageal cancer	0.0175	0.0219	CcSEcCtD
Flunisolide—Sneezing—Capecitabine—esophageal cancer	0.0148	0.0185	CcSEcCtD
Flunisolide—Rhinorrhoea—Cisplatin—esophageal cancer	0.0137	0.0172	CcSEcCtD
Flunisolide—Ageusia—Cisplatin—esophageal cancer	0.0137	0.0172	CcSEcCtD
Flunisolide—Infection—Carboplatin—esophageal cancer	0.0134	0.0168	CcSEcCtD
Flunisolide—Oral candidiasis—Capecitabine—esophageal cancer	0.0129	0.0161	CcSEcCtD
Flunisolide—Pain—Carboplatin—esophageal cancer	0.0116	0.0145	CcSEcCtD
Flunisolide—Laryngitis—Capecitabine—esophageal cancer	0.0114	0.0142	CcSEcCtD
Flunisolide—Throat sore—Capecitabine—esophageal cancer	0.0114	0.0142	CcSEcCtD
Flunisolide—Oropharyngeal discomfort—Capecitabine—esophageal cancer	0.0113	0.0141	CcSEcCtD
Flunisolide—Wheezing—Cisplatin—esophageal cancer	0.0108	0.0135	CcSEcCtD
Flunisolide—Hydrocortisone—ANXA1—esophageal cancer	0.0108	0.128	CrCbGaD
Flunisolide—Body temperature increased—Carboplatin—esophageal cancer	0.0107	0.0134	CcSEcCtD
Flunisolide—Rhinorrhoea—Capecitabine—esophageal cancer	0.0101	0.0127	CcSEcCtD
Flunisolide—Ageusia—Capecitabine—esophageal cancer	0.0101	0.0127	CcSEcCtD
Flunisolide—Dysphonia—Capecitabine—esophageal cancer	0.00997	0.0125	CcSEcCtD
Flunisolide—Chest discomfort—Capecitabine—esophageal cancer	0.00927	0.0116	CcSEcCtD
Flunisolide—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00902	0.0113	CcSEcCtD
Flunisolide—Lacrimation increased—Capecitabine—esophageal cancer	0.0089	0.0111	CcSEcCtD
Flunisolide—Nasal congestion—Cisplatin—esophageal cancer	0.00887	0.0111	CcSEcCtD
Flunisolide—Cataract—Capecitabine—esophageal cancer	0.00862	0.0108	CcSEcCtD
Flunisolide—Neck pain—Capecitabine—esophageal cancer	0.0083	0.0104	CcSEcCtD
Flunisolide—Dexamethasone—ANXA1—esophageal cancer	0.00804	0.0951	CrCbGaD
Flunisolide—Candida infection—Capecitabine—esophageal cancer	0.00783	0.00979	CcSEcCtD
Flunisolide—Irritability—Cisplatin—esophageal cancer	0.00771	0.00963	CcSEcCtD
Flunisolide—Nasopharyngitis—Cisplatin—esophageal cancer	0.00722	0.00903	CcSEcCtD
Flunisolide—Ear pain—Capecitabine—esophageal cancer	0.00698	0.00872	CcSEcCtD
Flunisolide—Gastroenteritis—Capecitabine—esophageal cancer	0.00672	0.00839	CcSEcCtD
Flunisolide—Abdominal discomfort—Cisplatin—esophageal cancer	0.00669	0.00836	CcSEcCtD
Flunisolide—Glossitis—Methotrexate—esophageal cancer	0.00663	0.00828	CcSEcCtD
Flunisolide—Increased appetite—Capecitabine—esophageal cancer	0.00634	0.00792	CcSEcCtD
Flunisolide—Vaginal inflammation—Methotrexate—esophageal cancer	0.00611	0.00763	CcSEcCtD
Flunisolide—Stomatitis—Cisplatin—esophageal cancer	0.00607	0.00758	CcSEcCtD
Flunisolide—Conjunctivitis—Cisplatin—esophageal cancer	0.00605	0.00756	CcSEcCtD
Flunisolide—Migraine—Capecitabine—esophageal cancer	0.00586	0.00732	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—KRT17—esophageal cancer	0.00583	0.0506	CbGpPWpGaD
Flunisolide—Vaginal infection—Methotrexate—esophageal cancer	0.00576	0.0072	CcSEcCtD
Flunisolide—Irritability—Capecitabine—esophageal cancer	0.00568	0.0071	CcSEcCtD
Flunisolide—Nasopharyngitis—Capecitabine—esophageal cancer	0.00532	0.00665	CcSEcCtD
Flunisolide—Lymphadenopathy—Methotrexate—esophageal cancer	0.00519	0.00649	CcSEcCtD
Flunisolide—Abdominal distension—Capecitabine—esophageal cancer	0.00518	0.00647	CcSEcCtD
Flunisolide—Bronchospasm—Capecitabine—esophageal cancer	0.00506	0.00633	CcSEcCtD
Flunisolide—Bronchitis—Capecitabine—esophageal cancer	0.00495	0.00618	CcSEcCtD
Flunisolide—Abdominal discomfort—Capecitabine—esophageal cancer	0.00493	0.00616	CcSEcCtD
Flunisolide—Malnutrition—Cisplatin—esophageal cancer	0.00486	0.00608	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00478	0.00598	CcSEcCtD
Flunisolide—Weight increased—Capecitabine—esophageal cancer	0.00468	0.00585	CcSEcCtD
Flunisolide—Pneumonia—Capecitabine—esophageal cancer	0.00461	0.00577	CcSEcCtD
Flunisolide—Vision blurred—Cisplatin—esophageal cancer	0.00458	0.00573	CcSEcCtD
Flunisolide—Tremor—Cisplatin—esophageal cancer	0.00456	0.00569	CcSEcCtD
Flunisolide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00451	0.00564	CcSEcCtD
Flunisolide—Stomatitis—Capecitabine—esophageal cancer	0.00447	0.00559	CcSEcCtD
Flunisolide—Urinary tract infection—Capecitabine—esophageal cancer	0.00446	0.00557	CcSEcCtD
Flunisolide—Conjunctivitis—Capecitabine—esophageal cancer	0.00446	0.00557	CcSEcCtD
Flunisolide—Malaise—Cisplatin—esophageal cancer	0.00439	0.00548	CcSEcCtD
Flunisolide—Prednisolone—CYP2A6—esophageal cancer	0.00433	0.0512	CrCbGaD
Flunisolide—Epistaxis—Capecitabine—esophageal cancer	0.00433	0.00541	CcSEcCtD
Flunisolide—Irritability—Methotrexate—esophageal cancer	0.00423	0.00529	CcSEcCtD
Flunisolide—Myalgia—Cisplatin—esophageal cancer	0.00414	0.00517	CcSEcCtD
Flunisolide—Rhinitis—Capecitabine—esophageal cancer	0.00413	0.00516	CcSEcCtD
Flunisolide—Anxiety—Cisplatin—esophageal cancer	0.00413	0.00516	CcSEcCtD
Flunisolide—Hypoaesthesia—Capecitabine—esophageal cancer	0.0041	0.00512	CcSEcCtD
Flunisolide—Discomfort—Cisplatin—esophageal cancer	0.00409	0.00511	CcSEcCtD
Flunisolide—Pharyngitis—Capecitabine—esophageal cancer	0.00409	0.00511	CcSEcCtD
Flunisolide—Oedema peripheral—Capecitabine—esophageal cancer	0.00406	0.00507	CcSEcCtD
Flunisolide—Betamethasone—CYP19A1—esophageal cancer	0.00404	0.0478	CrCbGaD
Flunisolide—Oedema—Cisplatin—esophageal cancer	0.00397	0.00496	CcSEcCtD
Flunisolide—Infection—Cisplatin—esophageal cancer	0.00394	0.00493	CcSEcCtD
Flunisolide—Erythema multiforme—Capecitabine—esophageal cancer	0.00389	0.00487	CcSEcCtD
Flunisolide—Tachycardia—Cisplatin—esophageal cancer	0.00387	0.00484	CcSEcCtD
Flunisolide—Hyperhidrosis—Cisplatin—esophageal cancer	0.00384	0.0048	CcSEcCtD
Flunisolide—Dexamethasone—NOS2—esophageal cancer	0.00376	0.0445	CrCbGaD
Flunisolide—CYP3A4—Codeine and Morphine Metabolism—ABCC2—esophageal cancer	0.00375	0.0325	CbGpPWpGaD
Flunisolide—Chills—Capecitabine—esophageal cancer	0.0037	0.00462	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—esophageal cancer	0.00367	0.00459	CcSEcCtD
Flunisolide—NR3C1—Nuclear Receptors—NR1I2—esophageal cancer	0.00365	0.0317	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00362	0.00452	CcSEcCtD
Flunisolide—Malnutrition—Capecitabine—esophageal cancer	0.00359	0.00448	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00356	0.00445	CcSEcCtD
Flunisolide—Dyspnoea—Cisplatin—esophageal cancer	0.00354	0.00442	CcSEcCtD
Flunisolide—Dysgeusia—Capecitabine—esophageal cancer	0.00351	0.00439	CcSEcCtD
Flunisolide—Back pain—Capecitabine—esophageal cancer	0.00347	0.00433	CcSEcCtD
Flunisolide—Decreased appetite—Cisplatin—esophageal cancer	0.00345	0.00431	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—esophageal cancer	0.00344	0.00429	CcSEcCtD
Flunisolide—Pain—Cisplatin—esophageal cancer	0.00339	0.00424	CcSEcCtD
Flunisolide—Vision blurred—Capecitabine—esophageal cancer	0.00338	0.00422	CcSEcCtD
Flunisolide—Tremor—Capecitabine—esophageal cancer	0.00336	0.0042	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—esophageal cancer	0.00333	0.00416	CcSEcCtD
Flunisolide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00333	0.00416	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—esophageal cancer	0.00332	0.00415	CcSEcCtD
Flunisolide—Sweating—Methotrexate—esophageal cancer	0.00327	0.00409	CcSEcCtD
Flunisolide—Feeling abnormal—Cisplatin—esophageal cancer	0.00327	0.00409	CcSEcCtD
Flunisolide—Malaise—Capecitabine—esophageal cancer	0.00323	0.00404	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—CRTC1—esophageal cancer	0.00323	0.028	CbGpPWpGaD
Flunisolide—Epistaxis—Methotrexate—esophageal cancer	0.00322	0.00403	CcSEcCtD
Flunisolide—Vertigo—Capecitabine—esophageal cancer	0.00322	0.00403	CcSEcCtD
Flunisolide—Syncope—Capecitabine—esophageal cancer	0.00322	0.00402	CcSEcCtD
Flunisolide—Dexamethasone—CYP1B1—esophageal cancer	0.0032	0.0379	CrCbGaD
Flunisolide—Palpitations—Capecitabine—esophageal cancer	0.00317	0.00396	CcSEcCtD
Flunisolide—Loss of consciousness—Capecitabine—esophageal cancer	0.00315	0.00394	CcSEcCtD
Flunisolide—Body temperature increased—Cisplatin—esophageal cancer	0.00314	0.00392	CcSEcCtD
Flunisolide—Cough—Capecitabine—esophageal cancer	0.00313	0.00391	CcSEcCtD
Flunisolide—Hypertension—Capecitabine—esophageal cancer	0.0031	0.00387	CcSEcCtD
Flunisolide—Chest pain—Capecitabine—esophageal cancer	0.00305	0.00381	CcSEcCtD
Flunisolide—Myalgia—Capecitabine—esophageal cancer	0.00305	0.00381	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—esophageal cancer	0.00304	0.0038	CcSEcCtD
Flunisolide—Anxiety—Capecitabine—esophageal cancer	0.00304	0.0038	CcSEcCtD
Flunisolide—Discomfort—Capecitabine—esophageal cancer	0.00302	0.00377	CcSEcCtD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—ADH7—esophageal cancer	0.00296	0.0257	CbGpPWpGaD
Flunisolide—Oedema—Capecitabine—esophageal cancer	0.00293	0.00366	CcSEcCtD
Flunisolide—Hypersensitivity—Cisplatin—esophageal cancer	0.00292	0.00365	CcSEcCtD
Flunisolide—Infection—Capecitabine—esophageal cancer	0.00291	0.00363	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—esophageal cancer	0.0029	0.00362	CcSEcCtD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALDOB—esophageal cancer	0.0029	0.0251	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.00289	0.025	CbGpPWpGaD
Flunisolide—Shock—Capecitabine—esophageal cancer	0.00288	0.0036	CcSEcCtD
Flunisolide—Fluticasone furoate—ABCB1—esophageal cancer	0.00287	0.0339	CrCbGaD
Flunisolide—Tachycardia—Capecitabine—esophageal cancer	0.00286	0.00357	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—KRT14—esophageal cancer	0.00285	0.0247	CbGpPWpGaD
Flunisolide—Asthenia—Cisplatin—esophageal cancer	0.00285	0.00356	CcSEcCtD
Flunisolide—Hyperhidrosis—Capecitabine—esophageal cancer	0.00283	0.00354	CcSEcCtD
Flunisolide—Chills—Methotrexate—esophageal cancer	0.00275	0.00344	CcSEcCtD
Flunisolide—Diarrhoea—Cisplatin—esophageal cancer	0.00272	0.00339	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—esophageal cancer	0.00267	0.00334	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00267	0.00333	CcSEcCtD
Flunisolide—Insomnia—Capecitabine—esophageal cancer	0.00265	0.00331	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—esophageal cancer	0.00261	0.00327	CcSEcCtD
Flunisolide—Dyspnoea—Capecitabine—esophageal cancer	0.00261	0.00326	CcSEcCtD
Flunisolide—CYP3A4—Tryptophan metabolism—ALDH3A2—esophageal cancer	0.00261	0.0226	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—esophageal cancer	0.0026	0.0225	CbGpPWpGaD
Flunisolide—Back pain—Methotrexate—esophageal cancer	0.00258	0.00323	CcSEcCtD
Flunisolide—Dyspepsia—Capecitabine—esophageal cancer	0.00258	0.00322	CcSEcCtD
Flunisolide—Decreased appetite—Capecitabine—esophageal cancer	0.00254	0.00318	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—esophageal cancer	0.00252	0.00315	CcSEcCtD
Flunisolide—Fatigue—Capecitabine—esophageal cancer	0.00252	0.00315	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—esophageal cancer	0.00252	0.00314	CcSEcCtD
Flunisolide—Rash—Cisplatin—esophageal cancer	0.0025	0.00313	CcSEcCtD
Flunisolide—Pain—Capecitabine—esophageal cancer	0.0025	0.00313	CcSEcCtD
Flunisolide—Constipation—Capecitabine—esophageal cancer	0.0025	0.00313	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—esophageal cancer	0.0025	0.00313	CcSEcCtD
Flunisolide—Dexamethasone—ABCC2—esophageal cancer	0.0025	0.0295	CrCbGaD
Flunisolide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00248	0.00309	CcSEcCtD
Flunisolide—Dexamethasone—CYP2A6—esophageal cancer	0.00247	0.0292	CrCbGaD
Flunisolide—Feeling abnormal—Capecitabine—esophageal cancer	0.00241	0.00301	CcSEcCtD
Flunisolide—Malaise—Methotrexate—esophageal cancer	0.00241	0.00301	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—esophageal cancer	0.0024	0.003	CcSEcCtD
Flunisolide—CYP3A4—Irinotecan Pathway—ABCC2—esophageal cancer	0.0024	0.0208	CbGpPWpGaD
Flunisolide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00239	0.00299	CcSEcCtD
Flunisolide—Nausea—Cisplatin—esophageal cancer	0.00236	0.00295	CcSEcCtD
Flunisolide—Dexamethasone—CYP19A1—esophageal cancer	0.00235	0.0278	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX1—esophageal cancer	0.00235	0.0203	CbGpPWpGaD
Flunisolide—Cough—Methotrexate—esophageal cancer	0.00233	0.00291	CcSEcCtD
Flunisolide—Urticaria—Capecitabine—esophageal cancer	0.00232	0.00291	CcSEcCtD
Flunisolide—Abdominal pain—Capecitabine—esophageal cancer	0.00231	0.00289	CcSEcCtD
Flunisolide—Body temperature increased—Capecitabine—esophageal cancer	0.00231	0.00289	CcSEcCtD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—esophageal cancer	0.0023	0.02	CbGpPWpGaD
Flunisolide—Methylprednisolone—ABCB1—esophageal cancer	0.00229	0.0271	CrCbGaD
Flunisolide—Myalgia—Methotrexate—esophageal cancer	0.00227	0.00284	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—esophageal cancer	0.00227	0.00284	CcSEcCtD
Flunisolide—Triamcinolone—PTGS2—esophageal cancer	0.00227	0.0268	CrCbGaD
Flunisolide—Discomfort—Methotrexate—esophageal cancer	0.00225	0.00281	CcSEcCtD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—esophageal cancer	0.0022	0.0191	CbGpPWpGaD
Flunisolide—Infection—Methotrexate—esophageal cancer	0.00216	0.0027	CcSEcCtD
Flunisolide—Hypersensitivity—Capecitabine—esophageal cancer	0.00216	0.00269	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—esophageal cancer	0.00211	0.00263	CcSEcCtD
Flunisolide—Asthenia—Capecitabine—esophageal cancer	0.0021	0.00262	CcSEcCtD
Flunisolide—Pruritus—Capecitabine—esophageal cancer	0.00207	0.00259	CcSEcCtD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—esophageal cancer	0.00205	0.0178	CbGpPWpGaD
Flunisolide—Diarrhoea—Capecitabine—esophageal cancer	0.002	0.0025	CcSEcCtD
Flunisolide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—esophageal cancer	0.00199	0.0173	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00198	0.00248	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—esophageal cancer	0.00197	0.00246	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—esophageal cancer	0.00194	0.00243	CcSEcCtD
Flunisolide—Dizziness—Capecitabine—esophageal cancer	0.00194	0.00242	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—esophageal cancer	0.00192	0.0024	CcSEcCtD
Flunisolide—NR3C1—Endoderm Differentiation—SOX2—esophageal cancer	0.0019	0.0165	CbGpPWpGaD
Flunisolide—Decreased appetite—Methotrexate—esophageal cancer	0.00189	0.00237	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—esophageal cancer	0.00188	0.00235	CcSEcCtD
Flunisolide—Pain—Methotrexate—esophageal cancer	0.00186	0.00233	CcSEcCtD
Flunisolide—Vomiting—Capecitabine—esophageal cancer	0.00186	0.00233	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—esophageal cancer	0.00186	0.022	CrCbGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.00185	0.0161	CbGpPWpGaD
Flunisolide—Rash—Capecitabine—esophageal cancer	0.00185	0.00231	CcSEcCtD
Flunisolide—Dermatitis—Capecitabine—esophageal cancer	0.00184	0.0023	CcSEcCtD
Flunisolide—Headache—Capecitabine—esophageal cancer	0.00183	0.00229	CcSEcCtD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—esophageal cancer	0.00183	0.0159	CbGpPWpGaD
Flunisolide—Feeling abnormal—Methotrexate—esophageal cancer	0.0018	0.00224	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00178	0.00223	CcSEcCtD
Flunisolide—Prednisone—ABCB1—esophageal cancer	0.00175	0.0207	CrCbGaD
Flunisolide—Nausea—Capecitabine—esophageal cancer	0.00174	0.00217	CcSEcCtD
Flunisolide—Urticaria—Methotrexate—esophageal cancer	0.00173	0.00216	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—esophageal cancer	0.00172	0.00215	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—esophageal cancer	0.00172	0.00215	CcSEcCtD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—esophageal cancer	0.00172	0.0149	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—ADCYAP1—esophageal cancer	0.0017	0.0148	CbGpPWpGaD
Flunisolide—Prednisolone—ABCB1—esophageal cancer	0.00161	0.0191	CrCbGaD
Flunisolide—Hypersensitivity—Methotrexate—esophageal cancer	0.0016	0.00201	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—SFN—esophageal cancer	0.00158	0.0137	CbGpPWpGaD
Flunisolide—Betamethasone—ABCB1—esophageal cancer	0.00158	0.0187	CrCbGaD
Flunisolide—Asthenia—Methotrexate—esophageal cancer	0.00156	0.00195	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—esophageal cancer	0.00154	0.00193	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—esophageal cancer	0.00149	0.00186	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—esophageal cancer	0.00144	0.0018	CcSEcCtD
Flunisolide—CYP3A4—Xenobiotics—CYP2A6—esophageal cancer	0.00144	0.0125	CbGpPWpGaD
Flunisolide—Vomiting—Methotrexate—esophageal cancer	0.00139	0.00173	CcSEcCtD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00138	0.012	CbGpPWpGaD
Flunisolide—Rash—Methotrexate—esophageal cancer	0.00137	0.00172	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—esophageal cancer	0.00137	0.00171	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—CYP26A1—esophageal cancer	0.00137	0.0118	CbGpPWpGaD
Flunisolide—Headache—Methotrexate—esophageal cancer	0.00136	0.00171	CcSEcCtD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00132	0.0115	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00132	0.0115	CbGpPWpGaD
Flunisolide—Nausea—Methotrexate—esophageal cancer	0.00129	0.00162	CcSEcCtD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1B1—esophageal cancer	0.00126	0.011	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00124	0.0107	CbGpPWpGaD
Flunisolide—Hydrocortisone—ABCB1—esophageal cancer	0.00123	0.0146	CrCbGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—esophageal cancer	0.00118	0.0102	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.00118	0.0102	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.00112	0.00968	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—RUNX3—esophageal cancer	0.0011	0.00952	CbGpPWpGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—esophageal cancer	0.00109	0.00944	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—SMAD4—esophageal cancer	0.00108	0.00941	CbGpPWpGaD
Flunisolide—Dexamethasone—PTGS2—esophageal cancer	0.00108	0.0128	CrCbGaD
Flunisolide—NR3C1—Circadian Clock—HIF1A—esophageal cancer	0.00105	0.00912	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—GAPDH—esophageal cancer	0.00101	0.00879	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.000989	0.00858	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—SOX2—esophageal cancer	0.000978	0.00849	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.000943	0.00818	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCB1—esophageal cancer	0.000919	0.0109	CrCbGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—CREBBP—esophageal cancer	0.000885	0.00768	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—BAX—esophageal cancer	0.000884	0.00767	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—HIF1A—esophageal cancer	0.000867	0.00752	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—CREBBP—esophageal cancer	0.000859	0.00745	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.000839	0.00728	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.000834	0.00724	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.000828	0.00718	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—esophageal cancer	0.000804	0.00697	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—NOTCH1—esophageal cancer	0.0008	0.00694	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—ALDH2—esophageal cancer	0.000787	0.00682	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—SST—esophageal cancer	0.000761	0.0066	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.000732	0.00635	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00068	0.0059	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.000656	0.00569	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00063	0.00547	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000625	0.00542	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—esophageal cancer	0.000624	0.00541	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.00062	0.00538	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—EP300—esophageal cancer	0.000603	0.00523	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000598	0.00519	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1B1—esophageal cancer	0.000596	0.00517	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00059	0.00512	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—EP300—esophageal cancer	0.000585	0.00508	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00056	0.00486	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.000529	0.00459	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000524	0.00455	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000516	0.00447	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000499	0.00433	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000485	0.0042	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.000482	0.00419	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000482	0.00418	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000476	0.00413	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00046	0.00399	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	0.000457	0.00396	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.000453	0.00393	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000451	0.00391	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000447	0.00388	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	0.000447	0.00388	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	0.000443	0.00385	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RB1—esophageal cancer	0.00043	0.00373	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000429	0.00372	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	0.000425	0.00369	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	0.00042	0.00365	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.000391	0.00339	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	0.000389	0.00337	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000374	0.00325	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	0.000373	0.00324	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000367	0.00319	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	0.000361	0.00313	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	0.000356	0.00309	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	0.000345	0.003	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	0.000336	0.00291	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	0.000331	0.00287	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SMG6—esophageal cancer	0.000317	0.00275	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000313	0.00272	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	0.000309	0.00268	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	0.000304	0.00264	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.000281	0.00244	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	0.000274	0.00238	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	0.00026	0.00226	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	0.000257	0.00223	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000254	0.0022	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	0.000244	0.00212	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NR1I2—esophageal cancer	0.00024	0.00208	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000236	0.00205	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	0.000208	0.0018	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	0.000206	0.00179	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000205	0.00178	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	0.000195	0.00169	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000192	0.00167	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000174	0.00151	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PSME1—esophageal cancer	0.00016	0.00139	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—PSME2—esophageal cancer	0.00016	0.00139	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000158	0.00137	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH3—esophageal cancer	0.000151	0.00131	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH2—esophageal cancer	0.000135	0.00117	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SMAD4—esophageal cancer	0.000114	0.000985	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000105	0.00091	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000105	0.00091	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	9.36e-05	0.000812	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	8.92e-05	0.000773	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CA1—esophageal cancer	8.92e-05	0.000773	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH1—esophageal cancer	8.37e-05	0.000726	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CA2—esophageal cancer	8.15e-05	0.000707	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CREBBP—esophageal cancer	7.59e-05	0.000658	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADH7—esophageal cancer	7.58e-05	0.000658	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLCE1—esophageal cancer	7.58e-05	0.000658	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADH1B—esophageal cancer	6.65e-05	0.000577	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMP—esophageal cancer	6.35e-05	0.000551	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	6.18e-05	0.000536	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALOX15—esophageal cancer	6.02e-05	0.000522	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTO1—esophageal cancer	5.74e-05	0.000498	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TPI1—esophageal cancer	5.74e-05	0.000498	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDOB—esophageal cancer	5.51e-05	0.000478	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GAPDH—esophageal cancer	5.3e-05	0.00046	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CRABP1—esophageal cancer	5.25e-05	0.000456	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GNG7—esophageal cancer	5e-05	0.000434	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDH2—esophageal cancer	4.68e-05	0.000406	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—esophageal cancer	4.5e-05	0.000391	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—esophageal cancer	4.45e-05	0.000386	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	4.4e-05	0.000382	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO1—esophageal cancer	4.17e-05	0.000362	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS1—esophageal cancer	4.17e-05	0.000362	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PSME2—esophageal cancer	4.11e-05	0.000357	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PSME1—esophageal cancer	4.11e-05	0.000357	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	3.55e-05	0.000308	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	3.34e-05	0.000289	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.05e-05	0.000264	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.92e-05	0.000254	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.95e-05	0.000169	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—esophageal cancer	1.75e-05	0.000152	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.6e-05	0.000139	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—EP300—esophageal cancer	1.33e-05	0.000115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	9.84e-06	8.54e-05	CbGpPWpGaD
